Skip to main content
. 2022 Jun 30;15(6):691–702. doi: 10.1007/s40271-022-00584-w

Table 3.

Distribution-based estimates for key EORTC domain scores (N = 681)

EORTC domain Test–retest reliabilitya One-half standard deviationb Standard error of measurement
EORTC QLQ-C30 Physical Functioning 0.82 10.12 8.62
EORTC QLQ-LC13 Dyspnea 0.77 10.81 10.29
EORTC QLQ-LC13 Coughing 0.76 13.67 13.42
EORTC QLQ-LC13 Pain in Chest 0.62 12.06 14.95

EORTC European Organisation for Research and Treatment of Cancer, QLQ-C30 30-item core instrument, QLQ-LC13 13-item lung cancer module

aTest–retest reliability is the intraclass correlation coefficient using a two-way mixed effects regression model based on absolute agreement with screening data as the ‘test’ administration and Week 1 data as the ‘retest’ administration, using only participants who report the same value on the Global Health Status item at both administrations

b Based on Baseline scores